Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 2006
Gene Symbol: ELN
ELN
0.100 Biomarker group BEFREE Thus, SVAS may be more appropriately termed an elastin arteriopathy. 9649945 1998
Entrez Id: 4854
Gene Symbol: NOTCH3
NOTCH3
0.100 GeneticVariation group BEFREE Recently, an autosomal dominant form of cerebral arteriopathy (CADASIL) has been described in association with a Notch3 family gene on the short arm of chromosome 19. 9877528 1998
Entrez Id: 4854
Gene Symbol: NOTCH3
NOTCH3
0.100 GeneticVariation group BEFREE One hallmark of this arteriopathy due to mutations of Notch 3 gene is the presence of MRI signal abnormalities in both symptomatic and asymptomatic patients. 9710018 1998
Entrez Id: 59
Gene Symbol: ACTA2
ACTA2
0.070 Biomarker group BEFREE Recognition of clinical and radiological phenotypic patterns has facilitated the discovery of multisystem disorders associated with arterial ischemic stroke including ACTA2 arteriopathy and adenosine deaminase 2 deficiency. 30079825 2019
Entrez Id: 59
Gene Symbol: ACTA2
ACTA2
0.070 Biomarker group BEFREE Our literature search revealed 15 articles (58 cases) of confirmed ACTA2 cerebral arteriopathy. 30300893 2018
Entrez Id: 59
Gene Symbol: ACTA2
ACTA2
0.070 GeneticVariation group BEFREE Cerebral arteriopathy associated with heterozygous Arg179Cys mutation in the ACTA2 gene: Report in 2 newborn siblings. 27567161 2017
Entrez Id: 59
Gene Symbol: ACTA2
ACTA2
0.070 Biomarker group BEFREE While direct cerebrovascular bypass is technically feasible, patients with ACTA2 arteriopathy may be at increased risk for perioperative stroke compared with patients with moyamoya disease. 27176728 2016
Entrez Id: 59
Gene Symbol: ACTA2
ACTA2
0.070 GeneticVariation group BEFREE Cerebral arteriopathy associated with Arg179His ACTA2 mutation. 24353327 2014
Entrez Id: 59
Gene Symbol: ACTA2
ACTA2
0.070 GeneticVariation group BEFREE Cerebral arteriopathy associated with Arg179His ACTA2 mutation. 24293535 2013
Entrez Id: 59
Gene Symbol: ACTA2
ACTA2
0.070 GeneticVariation group BEFREE ACTA2 mutations cause a spectrum of extra-renal arteriopathy, leading to our second hypothesis that mutations are implicated in FMD. 21553326 2011
Entrez Id: 2147
Gene Symbol: F2
F2
0.060 GeneticVariation group BEFREE We suggest that prothrombin mutation but not FV Leiden should be considered as a modest genetic risk factor for large artery disease stroke subtype in the Moroccan population. 21701789 2012
Entrez Id: 2147
Gene Symbol: F2
F2
0.060 GeneticVariation group BEFREE In conclusion, our data suggest that FII G20210A and/or Leiden FV might be involved as risk factor for arterial disorders in about 5% of old subjects, justifying the opportunity of a genetic screening and an eventual preventive treatment, in particular in old subjects in which other and major risk factors, as hypertension and atherosclerosis, are detected. 21918818 2011
Entrez Id: 4524
Gene Symbol: MTHFR
MTHFR
0.060 GeneticVariation group BEFREE Polymorphism in the methylenetetrahydrofolate reductase (C677T) gene and homocysteine levels: a comparison in Brazilian patients with coronary arterial disease, ischemic stroke and peripheral arterial obstructive disease. 18040753 2009
Entrez Id: 4524
Gene Symbol: MTHFR
MTHFR
0.060 AlteredExpression group BEFREE Methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genotypes and haplotypes and plasma homocysteine levels in patients with occlusive artery disease and deep venous thrombosis. 18800176 2008
Entrez Id: 4524
Gene Symbol: MTHFR
MTHFR
0.060 GeneticVariation group BEFREE The frequency of T allele of MTHFR-677 was lower in healthy participants (0.355) than in patients with occlusive artery disease (0.388) and deep venous thrombosis (0.425). 18293456 2008
Entrez Id: 4524
Gene Symbol: MTHFR
MTHFR
0.060 GeneticVariation group BEFREE Our TDT analysis clearly demonstrates a lack of association between the T allele of the C677T mutation in MTHFR and cardiovascular artery disease, both for the general group and for different risk subgroups (smokers, hypertension, male sex, overweight and type A behaviour pattern) in the Spanish population. 12220440 2002
Entrez Id: 2147
Gene Symbol: F2
F2
0.060 GeneticVariation group BEFREE The role of this common polymorphism, as well as that of prothrombin levels, in determining the risk of arterial disease is still somewhat controversial. 11369682 2001
Entrez Id: 4524
Gene Symbol: MTHFR
MTHFR
0.060 GeneticVariation group BEFREE However, the results of most of the previous studies suggest that the C677T MTHFR mutation is not a significant risk factor for arterial disease. 10360632 1999
Entrez Id: 4524
Gene Symbol: MTHFR
MTHFR
0.060 GeneticVariation group BEFREE There was a high prevalence of homozygotes for the mutated MTHFR allele among the whole group of cases with arterial disease (OR = 2.35, p = 0.001). 10477457 1999
Entrez Id: 2147
Gene Symbol: F2
F2
0.060 GeneticVariation group BEFREE The relationship between the prothrombin (PT) 20210A allele and arterial disease is controversial. 10404757 1999
Entrez Id: 2147
Gene Symbol: F2
F2
0.060 GeneticVariation group BEFREE The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease. 9409210 1997
Entrez Id: 2147
Gene Symbol: F2
F2
0.060 GeneticVariation group BEFREE These data support the hypothesis that the prothrombin variant is a risk factor for venous thrombosis and suggest that it may also be a risk factor for arterial disease. 9423789 1997
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.040 AlteredExpression group BEFREE Influence of laser needle-knife on PI-3K, AKT and VEGF mRNA expression in cervical spondylotic arteriopathy model rabbits. 30899176 2019
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.040 Biomarker group BEFREE Effects of laser needle-knife therapy on vertebroarterial morphology and protein expression of PI-3K, AKT and VEGF in the carotid artery in a rabbit model of cervical spondylotic arteriopathy. 31485183 2019
Entrez Id: 7422
Gene Symbol: VEGFA
VEGFA
0.040 Biomarker group BEFREE Currently, about 200 patients have been treated with intramyocardial VEGF gene therapy for peripheral occlusive artery disease or for myocardial ischemia. 12582471 2002